Bristol-Myers Squibb - Company & Market Research Reports

Home /
Companies /
Bristol-Myers Squibb

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 476
Immune Disorders Drugs 202
Drug Discovery 170
Cardiovascular Drugs 157
Infectious Diseases Drugs 135
Biopharmaceuticals 130
Clinical Trials 125
Endocrine and Metabolic Disorders Drugs 110
Central Nervous System Drugs 100
Pharmaceuticals 95
Musculoskeletal Disorders Drugs 94
Leukemia Drugs 85
Hematological Drugs 84
Liver and Kidney Disorders Drugs 79
Lymphoma Drugs 62
Diabetes Drugs 55
Dermatological Drugs 55
Skin Cancer Drugs 51
Brain Cancer Drugs 45
Respiratory Drugs 44
Gastrointestinal Drugs 42
Mental Disorders Drugs 41
Lung Cancer Drugs 39
Drug Delivery 37
Pharmaceutical Intermediates 36
Immunosuppressive Drugs 34
Pharmaceutical Manufacturing 32
Infusions and Injectables 30
Liver Cancer Drugs 28
Analgesics 25
Drugs by Therapeutic Area 24
Bladder Cancer Drugs 24
Antibiotics 23
Kidney Cancer Drugs 22
Colon Cancer Drugs 20
HIV/AIDS Drugs 20
Schizophrenia Drugs 19
Prostate Cancer Drugs 18
Pancreatic Cancer Drugs 18
Urological Disorders Drugs 17
Sexual and Reproductive Health Drugs 15
Breast Cancer Drugs 14
Ovarian Cancer Drugs 14
Cervical Cancer Drugs 14
Cancer Vaccines 13
Thyroid Cancer Drugs 12
Psoriasis Drugs 12
Generic Drugs 10
Biosimilars and Biosuperiors 10
Over the Counter (OTC) Drugs 9
Vaccines 9
Transdermal and Transmucosal Drug Delivery 8
Anti-Obesity Drugs 8
Alzheimer's Disease Drugs 8
Optical Disorders Drugs 7
Uterine Cancer Drugs 6
Company Reports 5
Anxiety Drugs 4
Pharmacoeconomics 3
Cough and Cold Drugs 3
Vitamins and Dietary Supplements 3
Addiction Disorders Drugs 2
Animal Pharmaceuticals 2
Asthma Drugs 2
Inhalers and Nebulisers 1
Anesthetic Drugs 1
Allergy Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



274 reviews

2,452 Results (Page 25 of 123)
- Relevance
  Sort by

Liver Cancer - Pipeline Insight, 2024

 Clinical Trials
April 2024
240 Pages
Global

From

€2692EUR$3,000USD£2,317GBP

Non-Alcoholic Steatohepatitis Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,467GBP

Liver Diseases Therapeutics Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,467GBP

Alcoholic Hepatitis Treatment Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,467GBP

Chronic Kidney Disease Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,467GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Kidney Disease Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,467GBP

Late Stage Chronic Kidney Disease Drugs Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,467GBP

Edema Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II), Participant (Pediatrics, Adults), Study Design (Interventional Trials, Observational Trials), Type (Systemic Edema, Localized Edema), Region, and Segment Forecasts, 2023-2030

 Report
November 2023
175 Pages
Global

From

€5339EUR$5,950USD£4,595GBP

Glioblastoma Multiforme Therapeutics Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

 Report
January 2024
78 Pages
Global

From

€3500EUR$4,178USD£3,118GBP

Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

 Report
March 2023
545 Pages
Global

From

€2243EUR$2,500USD£1,931GBP

Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
March 2025
180 Pages
Global

From

€4038EUR$4,500USD£3,475GBP

Anti-Infective Agents Market Size, Share & Trends Analysis Report By Type (Antibacterial, Antiviral, Antifungal & Antiparasitic), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

 Report
November 2024
130 Pages
Global

From

€5339EUR$5,950USD£4,595GBP

Fibromyalgia Therapeutics Market by Drug Class, Distribution Channel - Global Forecast 2025-2030

 Report
October 2024
184 Pages
Global

From

€3181EUR$3,545USD£2,738GBP

€3534EUR$3,939USD£3,042GBP

End Stage Renal Disease (ESRD) Drug Market Report 2025

 Report
February 2025
200 Pages
Global

From

€4029EUR$4,490USD£3,467GBP

Chronic Kidney Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
February 2025
180 Pages
Global

From

€4038EUR$4,500USD£3,475GBP

Liver Fibrosis Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

 Report
February 2025
185 Pages
Global

From

€4038EUR$4,500USD£3,475GBP

Ulcerative Colitis Market Forecast - Epidemiology & Pipeline Analysis 2022-2027

 Report
August 2022
222 Pages
Global

From

€3140EUR$3,500USD£2,703GBP

Global Lung Cancer Drugs Market - Drivers, Restraints, Opportunities, Trends, and Forecast up to 2025

 Report
April 2019
93 Pages
Global

From

€2916EUR$3,250USD£2,510GBP

Global Non Small-Cell Lung Cancer Market By Type, By Treatment Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

 Report
October 2022
262 Pages
Global

From

€3203EUR$3,570USD£2,757GBP

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

 Report
July 2021
290 Pages
Global

From

€4306EUR$4,799USD£3,706GBP

2,452 Results (Page 25 of 123)
- 1
- 23
- 24
- 25
- 26
- 27

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.